SPRO filings
Corporate insider profile
Esther Rajavelu Filing Activity
Latest reported as See Remarks of Spero Therapeutics, Inc. (SPRO).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$63,352.40
- Latest transaction
- May 4, 2026
Affiliated corporations
Reported company relationships
Transaction history
